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Recommendations for interventions to control malaria in
pregnancy are often based on studies using birthweight as the
primary endpoint. Differences in birthweight may be attributable
partly to methodological difﬁculties. We performed a structured
search of the literature using ‘malaria’, ‘pregnancy’ and ‘birth
weight’ as search terms. Of the clinical trials reporting
birthweight, only 33% (14/43) gave information about the timing
of the measurement and details on the scales used. Seventy seven
per cent explained how gestational age was estimated. We propose
a standardised method for the measurement and reporting of
birthweight in future studies.
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Introduction
Malaria in pregnancy has a major impact on the health of
the mother and fetus. In endemic areas, malaria is esti-
mated to be responsible for 20% of low-birthweight (LBW)
infants, the greatest single risk factor for infant mortality.
1–3
However, malaria can cause both intrauterine growth
restriction (IUGR), related to the sequestration of malaria
parasites in the placenta, and preterm labour (PTL), which
is associated with symptomatic maternal illness in the third
trimester. IUGR and PTL can be distinguished only if the
gestational age is known with some accuracy.
4–6 This can
be difﬁcult in resource-poor settings. Many published clini-
cal trials on maternal malaria have recruited women at the
time of delivery, and birthweight (but not IUGR or PTL)
has been the major endpoint. Different types of interven-
tion may have different impacts on IUGR and PTL.
In this article, we review the methods used to obtain and
report birthweight in studies of malaria during pregnancy.
We also propose a systematic method for the reporting of
birth outcomes, with an emphasis on studies in resource-
poor settings.
Methods
A Medline (PubMed) search was performed with the search
terms ‘malaria’ AND ‘pregnancy’ AND ‘birth weight’ using
a combination of MeSH headings and keywords. The search
was not designed to identify all studies on malaria in preg-
nancy, but to analyse those that included birthweight
and malaria as outcomes. Only trials that speciﬁcally used
birthweight as the main outcome were included.
The search was limited to humans, clinical trials, rando-
mised controlled trials (RCTs), case reports and English
language articles from 1 January 1966 to 23 July 2009. Full
articles of all citations resulting from this search were
obtained. We scrutinised all articles for details of the meth-
odology used to obtain birthweight. Two investigators
independently performed eligibility assessment and, if
disagreements were not resolved by consensus, a decision
was made by a third author. Data from the included stud-
ies were extracted and entered onto an Excel spreadsheet
for collation and analysis. Information on the type of
scales, precision of scales, scale calibration, day of weight,
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pregnant women enrolled, proportion of infants weighed
and studies reporting signiﬁcant difference in birthweight
were extracted. When available, the method of gestational
age estimation and the potential confounders of birth-
weight measurements were also extracted.
Results
Sixty-three publications were identiﬁed. Three of these
reports were excluded because one was a review article
7 and
two did not report birthweight.
8,9 There were 43 different
trials and three case reports described in the remaining arti-
cles. The case reports did not contain sufﬁcient details on
the methodology used to measure birthweight and were
excluded.
10–12 Forty-three studies described in 59 publica-
tions were reviewed (Table S1, see Supporting informa-
tion).
13–72 Most (56%, 24/43) were studies on the prevention
of malaria by intermittent preventive treatment (IPTp) or
chemoprophylaxis in the African subcontinent (Table S1).
Weighing scales: model and accuracy
Different types of weighing scales were described, varying
from spring scales used in ﬁeld situations to very precise
digital scales in referral hospitals. Only 44% (19/43) of the
articles reported the type of scale (Table S2, see Supporting
information). Calibration of scales with standard weights
was reported in three studies.
46,55,68 Scale precision varied
from 1 to 100 g (Table S2).
In resource-limited, tropical, humid or dusty ﬁeld condi-
tions, electronic scales can break
56 or trained midwives can
be too busy to measure all babies;
15 however, only two
research teams reported such events. One study in Kenya
conﬁrmed birthweight measurement by a double reading,
and used the mean value for data analysis.
68
Table S2 shows the variation in the printed format of
birthweight. Most articles provided the mean ± standard
deviation (SD) birthweight in grams; those that reported a
signiﬁcant difference between groups (44% [19/43]) are
highlighted in bold in the table. One study reported a sig-
niﬁcant difference of 80 g between two groups, although
‘birthweight at the two hospitals was recorded to the near-
est 100 g’.
59 Three articles only reported the proportions of
LBW, but not the actual mean birthweight.
26,55,66 The aver-
age percentage of newborns that were included for birth-
weight analysis was 71% (range, 33–100%). In 58% (11/19)
of the studies that reported a signiﬁcant difference in birth-
weight, the result was based on the analysis of <80% of the
participants.
Date of weighing the infant
Delay in the weighing of the infant has an effect on the
reported result.
73,74 Seventy per cent (30/43) of the publica-
tions reported the time interval between the delivery and
measurement of birthweight, and 35% (15/43) included
babies weighed within 24 hours of birth (Table S2). The
percentage of babies that were included for birthweight
analysis is shown in Table S2. Some studies had a low pro-
portion (14%
53 or 15%
68) of infants weighed within
24 hours. Eight publications adjusted for the day of weight
using one of two formulae.
35,75 However, the actual formu-
lae were not provided, and different articles derived differ-
ent percentage adjustments despite referencing the same
formula. For example, some authors adjusted the weights
by 1% for weight measured on day 4,
33 and others, using
the same formula,
75 used a 3% correction,
15 whereas a 5%
adjustment was made using the formula described by
Greenwood et al.
35
Inclusion in birthweight analysis
Most of the included studies conﬁned their analysis of
birthweight to liveborn singletons (Table S2). Three publi-
cations included multiple deliveries (twins or trip-
lets).
54,59,70 Three teams speciﬁcally reported that twins
and congenital abnormalities were excluded from further
analysis.
41,43,72 The remaining publications did not mention
whether twins, stillborn infants or those with congenital
abnormalities were included in the analysis. Congenital
abnormalities were reported in 15 publica-
tions.
13,14,17,22,23,29,43,45,46,50,54,60–62,72 Eight studies (18%)
reported the length of the infant at birth and, of these, four
reported IUGR.
41,50,64,72
Method of gestational age estimation
Gestational age is deﬁned as the time elapsed from the ﬁrst
day of the last menstrual period (LMP), if known, to the
day of delivery.
76 Gestational age can then be divided into
blocks depending largely on neonatal viability (see Fig-
ure 1). The World Health Organization (WHO) uses a
22-week threshold to deﬁne miscarriage, but different deﬁ-
nitions continue to be used. In the articles reviewed, the
method of estimating gestational age was described in 77%
(33/43) of the publications. Table 1 shows that the
Figure 1. Deﬁnitions of pregnancy partitions. Maternal mortality can
occur whilst pregnant or up to 42 days after termination of pregnancy.
Rijken et al.
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used method.
SFH
This measurement enables the gestational age to be calcu-
lated, but the formulae differ between populations.
72,77,78
Several publications report SFH to be inaccurate
34,43,68;
however, it was the most common single method used
to describe gestational age in this review
(Table 1).
24,28,32,34,40,45,51,52,54–56,60,61,72
LMP
The use of LMP was reported to be inaccurate in studies in
which another method of gestational age estimation was
available.
26,41,43,64,65 Examples of such inaccuracies were
because the women could not recall their LMP,
26,50 or
there was no menstruation between two consecutive preg-
nancies.
43 One study reported 22% of pregnancies in which
the ultrasound measurement of fetal size was more than
two SDs above or below the mean for gestation calculated
from the menstrual history.
26 In another study, estimation
of gestational age was based on the identiﬁcation of ‘quick-
ening’, which was interpreted as an indication that the ges-
tational age was more than 18 weeks.
42 A combination of
LMP and SFH was used to estimate gestational age in six
studies.
15,38,41,46,63,67 One study that compared postnatal
tests and LMP/SFH reported, ‘an unacceptably high num-
ber of women had pregnancies of more than 44 weeks,
which makes the usefulness of LMP for assessment of ges-
tational age doubtful’ and ‘gestational age derived from
SFH is not reliable, with a range of 20–50 weeks’.
43
Newborn gestational age assessment
The number of physical and neuromuscular maturity crite-
ria examined in standardised neonatal scoring systems is
critical to the accuracy of the test.
79 However, a number of
modiﬁcations to the methods of Ballard
43 and Dubo-
witz
80,81 have been used in resource-poor settings. Newborn
tests have been reported to be less accurate when performed
after 12–20 hours of age,
22 and to be time consuming.
56
Ultrasound gestational age assessment
Ultrasound measurement to estimate gestational age was
reported from Kenya,
26 Sudan
13 and Thailand.
14,50
In Benin, ultrasound scans were limited to patients who
could afford to pay, but it was not reported how many
women were scanned.
62
Confounding factors
Several factors were reported to have an impact on birth-
weight, including maternal smoking (n = 2),
66,72 high
blood pressure or pre-eclampsia (n = 9),
17,23,26,32,60–62,66,72
maternal infections (e.g. chorioamnionitis) as risk factors
for premature labour (n = 3),
29,45,61 parity, height and
nutritional status of the mother, number of antenatal clinic
visits, rainy season and sex of the baby.
17,23,24,29,45,61,63–66,72
The sex of the newborn was reported in 40% (17/43) of
studies. A few authors make reference to the problem of
‘infants that were not weighed’, attributed to highly mobile
rural populations and large numbers of home deliveries
resulting in missing delivery information.
34,55,69 These
missing data may introduce bias, and one study showed
that the loss of contact with subjects during follow-up was
Table 1. Reporting of estimation of gestational age during pregnancy or in the postpartum period
Postnatal dating
method
Pregnancy dating Total
None LMP SFH LMP/SFH US
No postnatal test 10
19,20,23,27,35,47,49,58,59,69 3
16,22,70 8
28,32,33,40,51,53,55,60 3
15,46,63 4*
13,14,26,62 28
Ballard 1
31 01
45 2
41,67 04
Capurro 0 1
66 00 0 1
Dubowitz 1
17 1
64 4
24,54,61,72 1**
38 1
50 8
Lubchenko 1***
29 00 0 0 1
Other 0 0 1****
56 00 1
Total 13 5 14 6 5 43
LMP, last menstrual period; SFH, symphysis–fundal height; US, ultrasound.
*Ultrasound-derived gestational age assessment was used when menstrual dates were unknown (31%) or when the measurement of fetal size
was more than two standard deviations above or below the mean for gestation calculated from the menstrual history (22%).
26 Only women who
could afford to pay had an ultrasound dating scan in Benin.
62
**If the discrepancy between the LMP- and Dubowitz-derived gestational age was more than 14 days, the Dubowitz score was used.
38
***The gestational age was determined using the Ballard score. Anthropometric parameters and gestational age were used to classify the babies
using a Lubchenko chart as preterm, term and postdate.
29,30
****Midwives and Mother and Child Health aids recorded newborns as being full term or premature using personal experiences and based on
the indicators for rapid assessment of maturity.
56
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group.
20
Discussion
Considerable effort by researchers and the pregnant women
themselves has been devoted to determine the impact of
antimalarial interventions on birthweight, often under difﬁ-
cult conditions. Important information regarding the meth-
odology and reporting of birth outcome data is often
missing or inaccurately reported. Journal space restrictions
may not allow authors to describe completely what they
actually did and this is a potential limitation of our review.
This article does not question the association between
malaria and birthweight reduction, but highlights that the
conclusions drawn about the effects of interventions based
on differences in birthweight could partly be explained by
inaccuracy in measurement methods.
Gestational age estimation
When designing and conducting perinatal research studies,
careful selection of the method of gestational age estima-
tion is necessary, as ﬁndings can differ considerably accord-
ing to the method.
82 When differences in birthweight are
found, a bias caused by the selection of a particular method
must be considered as an alternative explanation for any
association found.
82
An error in gestational age estimation of even 1 week has
major implications on birthweight. The weight gain of a
fetus in the late third trimester can be as much as 250 g per
week:
83 this value is similar to the reduction in weight
attributable to malaria.
1–3 Ideally, gestational age should be
estimated by fetal crown–rump length (CRL) or early sec-
ond-trimester ultrasound, which is the standard in resource-
rich countries
84–86 and is becoming available in developing
countries.
87 When no reliable LMP, SFH or ultrasound
measurements are available, postnatal examination of the
newborn, with clinical scoring for external and/or neurologi-
cal characteristics, can be used. These methods can be
performed by locally trained paramedical health workers or
nurses.
43,88 The Dubowitz
80 examination for the estimation
of gestational age is recommended from 6 to 72 hours of
life, which can make it difﬁcult to include home births.
Weighing scales and reporting of birthweight data
All that is needed to measure newborn weight is a scale.
As a result, birthweight is frequently used as the only item
to describe birth outcome. To describe the type of growth
restriction caused by malaria, additional parameters, such
as gestational age, newborn length and/or head circumfer-
ence measurements, are required.
The accuracy of the equipment used to measure birth-
weight is paramount.
89 It is preferable to use scales that
have been registered for medical use, and the name, model
and accuracy should be reported, especially if newborns are
weighed at home. In the articles included here, none com-
pared birthweight of home- and hospital-delivered babies,
but this has the potential for large differences in measure-
ments. Although some studies reported weight to the near-
est gram,
29,31,54,64 the reported accuracy by the
manufacturer is usually of the order of 10 g, even though
some digital scales may provide readouts to the nearest
gram.
Research teams should be adequately trained in obtain-
ing and reporting measurements. Ideally, research measure-
ments should be taken by two different trained observers
who are blind to the results obtained by the other, with
measurements repeated that exceed preset maximum allow-
able differences.
90 A standard method of calibrating scales
should also take place at least once a week. With a sufﬁ-
cient sample size of newborns, birthweight is a normally
distributed continuous variable, so that the presentation of
such data would be expected to include the mean ± SD, as
well as the minimum and maximum (range).
Date of weight
Normal birthweight reduction can be as much as 10% by
day 3,
73,74 and, in a 3000-g baby, this would result in a
weight reduction of 300 g; this is within the order of mag-
nitude of the effect described for malaria in pregnancy.
Consequently, the day the newborn is weighed has impor-
tant implications for research, particularly as a large pro-
portion of women in resource-poor settings deliver at
home, and delays in the recording of birthweight are
expected. Ideally, birthweight should be obtained within
24 hours of birth or, if taken after 24 hours, a correction
formula could be applied. However, blanket correction fac-
tors do not account for the differences in postnatal weight
loss as a result of birthweight categories,
91 gravidity/par-
ity,
92 race, asphyxia
92 and age at the initiation of breast-
feeding.
92 In the context of RCTs, the proportion of infants
weighed on different days should not be signiﬁcantly differ-
ent between the groups.
Birthweight analysis
The inclusion of multiple pregnancies, stillbirths or infants
with congenital abnormalities will have an impact on birth-
weight analysis. Although such pregnancies need to be
reported, they should not be included in any analysis of
birthweight. Whether minor congenital abnormalities have
an impact on birthweight is debatable but, for the sake of
consistency, they should probably be excluded from any
birthweight analysis in the context of clinical trials. Never-
theless, it is important to highlight that congenital abnor-
malities will not be reliably reported without an adequate
examination of the newborn by a trained observer and a
Rijken et al.
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has established a pregnancy registry (http://apps.who.int/
tdr/svc/grants/calls/call-contributions) that will include
the prevalence of birth defects in Asia, Africa and Latin-
America, and classiﬁcation using International Classiﬁca-
tion of Diseases (ICD10).
Confounders
Most potential factors confounding birthweight can be
detected by adequate antenatal and intrapartum care. Inclu-
sion of gender in the analysis could be used as an internal
validity check, as female newborns are lighter than
males.
93,94 Although clinical trials often exclude women
with known medical or obstetric problems, some could
arise after inclusion and should be controlled for, for
example, hypertension (eclampsia, pre-eclampsia, preg-
nancy-induced hypertension), infections (pyelonephritis,
sexually transmitted infections, local area-speciﬁc infec-
tions, e.g. typhoid, scrub typhus), obstetric problems, such
as preterm labour, and whether there is a recognised trig-
ger, for example, symptomatic malaria or pyelonephritis.
RCTs could minimise the effect of potential confounders,
but they should be included in any (multivariate) analysis.
Birthweight may not necessarily be the best method to
evaluate the efﬁcacy of interventions against malaria in
pregnancy. The study of IUGR and the type of growth
restriction (symmetrical or asymmetrical) requires addi-
tional parameters, including gestational age, newborn
length and/or head circumference measurements.
Conclusions
Differences in birthweight are often used to compare the
efﬁcacy of interventions aimed to reduce the impact of
malaria during pregnancy.
95–98 Such differences can clearly
be affected by inaccuracies in measurement methods, and
confounders such as those affecting gestational age or time
of weighing. The reporting of birthweight and gestational
age in maternal malaria studies can be improved. Simple
methodological guidelines for reporting birth outcome,
with an emphasis on studies of malaria in pregnancy, are
provided (Table 2).
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Table 2. Recommendations
Birthweight
• Measure birthweight on all newborns (alive or stillborn) as soon as possible after birth, preferably before 24 hours
• Only liveborn singletons without congenital abnormalities should be included in birthweight analysis
• Report the actual number of newborn babies included in the birthweight analysis
• Report the time interval (in days) between birth and the measurement of birthweight
• Certiﬁed medical scales should be used
• Report the name, model and accuracy of the weight scale and state whether the scale was sufﬁciently sensitive to detect any difference identi-
ﬁed. Scales should be calibrated on a weekly basis
• Head circumference and length of the newborn should be measured
• Regular standardisation sessions and quality control checks of the measurers are required
90
• The sex of the baby should be recorded
Gestational age assessment
• Report the method of estimating gestational age
• A suggested algorithm to obtain the best estimate for the woman is, in order of priority: (1) ultrasound at <24 weeks by measuring, prefera-
bly, the crown–rump length (8–14 weeks) or head circumference (15–24 weeks); (2) if ultrasound not available, validated newborn gestational
age assessment; (3) if (1) and (2) not available, the date of the last menstrual period or the symphysis–fundal height
• Analysis using birthweight or low birthweight should be controlled for gestational age
• Methods used to estimate gestational age should have regular (yearly) standardisation sessions and ongoing quality control
(www.medscinet.net/intergrowth/protocol.aspx)
• Bias caused by the selection of a particular dating method—or no dating method—should always be considered as an alternative explanation
for any identiﬁed associations
65
Confounders
• Potential confounders should be diagnosed and included in the birthweight analysis
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